Latest news
Why Tarsus Pharmaceuticals (TARS) Is Up 9.7% After Raising XDEMVY 2026 Sales Guidance And Acquiring Alkeus - simplywall.stsimplywall.st · Sun, 09 Aug 2026 08:50:33 GMTTarsus Strikes Up to $800M Deal for Alkeus, Entering Heated Stargardt Disease Race - finance.biggo.comfinance.biggo.com · Fri, 07 Aug 2026 18:41:00 GMTAmazon Pharmacy to Offer GLP-1 Delivery Service | PharmExec - Pharmaceutical ExecutivePharmaceutical Executive · Fri, 07 Aug 2026 18:02:55 GMTTarsus secures USD 125m to fund Alkeus acquisition and expand eye care pipeline - AllSciAllSci · Fri, 07 Aug 2026 14:59:09 GMTTarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals for $450 Million - Pharmaceutical ExecutivePharmaceutical Executive · Fri, 07 Aug 2026 13:52:54 GMTTarsus joins Stargardt race to market with $800m Alkeus takeover - Pharmaceutical TechnologyPharmaceutical Technology · Fri, 07 Aug 2026 13:43:10 GMTTarsus to acquire Alkeus Pharma, adding retina repertoire - The Pharma LetterThe Pharma Letter · Fri, 07 Aug 2026 11:54:03 GMTTarsus to Acquire Alkeus in $450 Million Deal, Reports Strong Quarter and Half - VisionMonday.comVisionMonday.com · Fri, 07 Aug 2026 04:24:00 GMT